NASDAQ:PCRX - Pacira Biosciences Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $41.31 +2.16 (+5.52 %) (As of 04/24/2019 01:59 PM ET)Previous Close$39.15Today's Range$39.00 - $41.4352-Week Range$30.00 - $55.00Volume323,462 shsAverage Volume571,787 shsMarket Capitalization$1.70 billionP/E Ratio142.45Dividend YieldN/ABeta1.47 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Pacira Biosciences (NASDAQ:PCRX) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.17 Wall Street analysts have issued ratings and price targets for Pacira Biosciences in the last 12 months. Their average twelve-month price target is $54.50, suggesting that the stock has a possible upside of 31.93%. The high price target for PCRX is $85.00 and the low price target for PCRX is $33.00. There are currently 3 sell ratings, 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.292.332.472.37Ratings Breakdown: 3 Sell Rating(s)6 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)3 Sell Rating(s)6 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)7 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)8 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $54.50$54.0667$55.1333$48.4118Price Target Upside: 31.93% upside47.24% upside13.30% upside2.76% upsidePacira Biosciences (NASDAQ:PCRX) Consensus Price Target History Pacira Biosciences (NASDAQ:PCRX) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails4/9/2019Piper Jaffray CompaniesSet Price TargetBuy$55.00Low3/8/2019WedbushReiterated RatingOutperform$85.00Low3/8/2019Stifel NicolausReiterated RatingPositive ➝ Sell$33.00Low3/1/2019BMO Capital MarketsSet Price TargetHold$44.00Medium3/1/2019CowenReiterated RatingHoldLow2/12/2019National SecuritiesInitiated CoverageSellMedium2/1/2019MizuhoDowngradeNeutral ➝ UnderperformHigh11/2/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$45.00 ➝ $50.00Low11/2/2018Jefferies Financial GroupBoost Price TargetBuy$60.00Low11/2/2018Royal Bank of CanadaSet Price TargetBuy$60.00High11/2/2018HC WainwrightBoost Price TargetBuy$60.00High11/1/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Buy$56.00 ➝ $63.00High11/1/2018Needham & Company LLCSet Price TargetBuy$60.00High10/10/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$46.00 ➝ $48.00High10/2/2018Canaccord GenuitySet Price TargetHold ➝ Hold$45.00 ➝ $49.00Low8/6/2018BarclaysBoost Price TargetOverweight ➝ Buy$40.00 ➝ $50.00Low5/17/2018OppenheimerReiterated RatingHoldLow4/8/2018Seaport Global SecuritiesSet Price TargetBuy$48.00Medium1/2/2018Leerink SwannInitiated CoverageMkt Perform ➝ Market Perform$46.00Low11/16/2017Janney Montgomery ScottSet Price TargetSell$27.00N/A9/28/2017Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$41.00Medium9/7/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformLow9/6/2017UBS GroupInitiated CoverageMarket PerformMedium(Data available from 4/24/2017 forward) This page was last updated on 4/24/2019 by MarketBeat.com StaffFeatured Article: Certificate of Deposit (CD) For Risk Adverse Investors?